期刊文献+

老年糖尿病患者骨密度变化和骨代谢指标与胰岛素抵抗关系的初步探讨 被引量:9

Correlation of bone density and metabolism with insulin resistance in aged diabetic patients
下载PDF
导出
摘要 目的探索老年糖尿病患者胰岛素抵抗(IR)对维生素D(vitD)代谢和骨代谢影响。方法纳入2011年01月至2013年12月于本院内分泌科住院的65~89岁的2型糖尿病患者55例。采集病例资料,进行口服葡萄糖糖耐量试验、胰岛素和C肽释放实验,检测骨转换指标、进行双光能x线骨密度检查,分析该组患者葡萄糖代谢、I嬲寸骨代谢的影响。结果血清糖化血红蛋白(HbAlc)水平与血清维生素D3(VitD3)呈负相关(r=-0.42,P=0.019),与甲状旁腺激素(PTH)呈正相关(r=0.40,P=0.05);空腹C肽(FCP)与PTH呈正相关(r=0.46,P=0.015);恒稳态模型评估(HOMA).B也与PTH呈正相关(r=0.56,P=0.004);HOMA-C肽(CR)与骨钙素(OCN)呈正相关(r=0.461,P=0.031),也和PTH呈正相关(r=0.43,P=0.028)。空腹血糖、HbAlc以及HOMA-β、HOMA-CR以及骨转换指标和任何部位骨密度T值均无显著相关性。结论在老年糖尿病患者中,改善IR、及时纠正vitD缺乏或不足对预防骨质疏松具有重要临床意义。 Objective To determine the effects of insulin resistance (IR) on bone metabolism and vitamin D metabolism in the elderly patients with diabetes mellitus(DM). Methods A total of 55 patients with type 2 DM at the age ranging from 65 to 89 years admitted in our department from January 2011 to December 2013 were recruited in this study. All of them were tested for oral glucose tolerance test, insulin release test and C-peptide release test. Serum levels of vitamin D3 (VitD3) and parathyroid hormone (PTH), and biomarkers for bone metabolism, including osteocacin (OCN) and carboxy-terminal 13 collagen crosslinks (β-CTX) were also detected. Bone mineral density (BMD) was measured by dual energy X-ray absorptiometry. Correlation analysis was performed on the effects of glucose metabolism and IR on bone metabolism. Results In the cohort, the serum level of glycosylated hemoglobin (HbAlc) was negatively correlated with that of VitD3 (r =-0.42, P = 0.019), bat positively with PTH (r = 0.40, P = 0.05). PTH was also positively related to fasting C peptide (FCP)( r= 0.40, P= 0.015) and Homeostasis Model Assessment(HOMA-13) (r= 0.56, P= 0.004). Bone formation marker OCN was in a positive correlation with HOMA-calretnin (HOMA-CR, r = 0.461, P = 0.031), while PTH was positively related to HOMA-CR either (r = 0.43, P = 0.028). But no correlation was seen in T values of BMD from every region of the total body with blood glucose, HbAlc, HOMA-β, HOMA-CR and bone metabolic markers. Conclusion For aged patients with diabetes, it is of great clinical significance to ameliorate IR and timely treat VitD deficiency or insufficiency in order to prevent osteoporosis.
出处 《中华老年多器官疾病杂志》 2014年第7期494-498,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 郑州大学第一附属医院青年创新基金项目
关键词 糖尿病 2型 胰岛素抵抗 骨质疏松 骨密度 骨质疏松性骨折 肌肉骨骼生理学现象 diabetes mellitus, type 2 insulin resistance osteoporosis bone density osteoporotic fractures musculoskeletalphysiological phenomena
  • 相关文献

参考文献22

  • 1WHO Scientific Group. World Health Organization (2007) Assessment of Osteoporosis at the Primary Health Carelevel[Z]. 2007. 被引量:1
  • 2王志芳,吴文迅,郑丽丽,韩超.2011年河南地区部分50岁以上人群骨质疏松性骨折发病特点初步研究[J].中国骨质疏松杂志,2012,18(12):1138-1139. 被引量:6
  • 3Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J]. Lancet, 2011, 378(9785): 31-40. 被引量:1
  • 4中华人民共和国卫生部.2012年中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2013. 被引量:5
  • 5Freedman BI, Divers J, Palmer ND. Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures[J]. Am J Kidney Dis, 2013, 62(6): 1165-1175. 被引量:1
  • 6王晓平,丁洪流.老年糖尿病女性继发性骨质疏松及其相关骨折(英文)[J].中国循证医学杂志,2008,8(7):517-524. 被引量:7
  • 7Carnevale V, Morano S, Fontana A, et al. Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross-sectional study[J]. Diabetes Metab Res Rev, 2014, 30(4): 313-322. 被引量:1
  • 8Khalil N, Sutton-Tyrrell K, Strotmeyer ES, et al. Menopausal bone changes and incident fractures in diabetic women: a cohort study[J]. Osteoporos Int, 2011, 22(5): 1367-1376. 被引量:1
  • 9Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus[J]. Bonekey Rep, 2012, 1: 36. 被引量:1
  • 10Eller-Vainicher C, Zhukouskaya VV, Tolkachev YV, et al. Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis[J]. Diabetes Care, 2011, 34(10): 2186-2191. 被引量:1

二级参考文献48

  • 1陈蓟,肖德明,林博文,徐忠世,王华,黎伟凡.大鼠骨质疏松模型中血清瘦素与钙磷含量相关性研究[J].中国骨肿瘤骨病,2006,5(4):233-235. 被引量:8
  • 2Hanley DA, Brown JP, Tenenhouse A, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral detormities in men and women 50 yeases of age and older:cross-sectional results from the Canadian Multicentre Osteoprosis Study. J Bone Miner Res,2003,18 : 784-790. 被引量:1
  • 3Kumeda Y, Inaba M, Nishizawa. Secondary osteoporosis and its treatment: diabetes mellitus. Nippon Rinsho, 1998,56: 1579-1586. 被引量:1
  • 4Takagi M, Kasayama S, Yamamoto T, et al. Advanced glycosylation end-products stimulate interleukin-6 production by human bone-derlved cells. J Bone Res, 1997,12:439. 被引量:1
  • 5National Osteoporosis Foundation: available at http://www.nof.org/ osteoporosis/diseasefacts.htm. Accessed: January 11, 2008. 被引量:1
  • 6Cooper C. Epidemiology of osteoporosis. Osteoporos Int, 1999, 9(Suppl 2): S2-8. 被引量:1
  • 7Stein E & Shane E. Secondary osteoporosis. Endocrinology and Metabolism Clinics of North America, 2003, 1:115-134. 被引量:1
  • 8Tuominen JT, Impivaara O, Puukka P, et al. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care, 1999, 22: 1196-1200. 被引量:1
  • 9McNair P, Christiansen C, Christensen MS, et al. Development of bone mineral loss in insulin-treated diabetes: a 112 years follow-up study in sixty patients. Eur J Clin Invest, 1981, 11: 55-59. 被引量:1
  • 10Forst T, Pfutzner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabetes Med, 1995, 12: 874-879. 被引量:1

共引文献25

同被引文献68

引证文献9

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部